Abstract
Synthesis of the carbothioamides (5, 13, 22) was performed starting from 3H-1,2,4-triazol-3-ones (2, 17) by several steps, and then, these carbothioamides was converted to triheterocyclic compounds incorporating 1,2,4-triazole, imidazole and 1,3-thiazol(idinone) moieties. The reaction of compound 2 with 3,4-difluoronitrobenzene afforded the 2-(2-fluoro-4-nitrophenyl) derivative, 10. Compound 10 was converted to the arylideneamino derivatives (12a, b) via the reduction of nitro group. On the other hand, the treatment of the hydrazide (20) that was obtained starting from 17, with several aromatic aldehydes generated the corresponding arylidenhydrazides (21a–c). Mannich reaction between compound 2 and a suitable heterocyclic amine resulted in the N-alkylation of 2. All newly synthesized compounds were screened for their antimicrobial activities. In general, most compounds except 22 were Found (%) to be active against Mycobacterium smegmatis, Candida albicans and/or Saccharomyces cerevisiae. Furthermore, 9a and b, which are Mannich bases incorporating morpholine or piperazine nucleus, exhibited excellent antimicrobial activity on test microorganisms. In addition, the hydrazide, 4, was Found (%) to have activity towards Ec and Yp.
Similar content being viewed by others
References
Abdel-Megeed AM, Abdel-Rahman HM, Alkaramany GES, El-Gendy MA (2009) Design, synthesis and molecular modeling study of acylated 1,2,4-triazole-3-acetates with potential anti-inflammatory activity. Eur J Med Chem 44:117–123
Almajan GL, Barbucenau SF, Almajan ER, Draghici C, Saramet G (2009) Synthesis, characterization and antibacterial activity of some triazole Mannich bases carrying diphenylsulfone moieties. Eur J Med Chem 44:3083–3089
Alvarez R, Velazquez S, Sanfelix A, Aquaro S, De Clercq E, Perno CF, Karlsson A, Balzarini J, Camarasa MJ (1994) 1,2,3-triazole-[2′,5′-bis-o-(tert-butyldimethylsilyl)-beta-d-ribofuranosyl]-3′-spiro-5″-(4″-amino-1″,2″-oxathiol 2″,2″-dioxide) (tsao) analogs-synthesis and anti-HIV-1 activity. J Med Chem 37:4185–4194
Aridoss G, Balasubramanian GAS, Parthiban P, Kabilan S (2007) Synthesis, stereochemistry and antimicrobial evaluation of some N-morpholinoacetyl-2,6-diarylpiperidin-4-ones. Eur J Med Chem 42:851–860
Basoglu S, Yolal M, Demirbas A, Bektas H, Abbasoglu R, Demirbas N (2012) Synthesis of linezolid-like molecules and evaluation of their antimicrobial activities. Turk J Chem 36:37–53
Bayrak H, Demirbas A, Demirbas N, Alpay-Karaoglu S (2010) Cyclization of some carbothioamide derivatives containing antipyrine and triazole moieties and investigation of their antimicrobial activities. Eur J Med Chem 45:4726–4732
Bektas H, Demirbas A, Demirbas N, Bayrak H, Alpay Karaoglu S (2010a) Synthesis and antimicrobial activities of some new biheterocyclic compounds containing 1,2,4-triazol-3-one and 1,3,4-thiadiazole moieties. Turk J Chem 34:517–527
Bektas H, Karaali N, Sahin D, Demirbas A, Alpay Karaoglu S, Demirbas N (2010b) Synthesis and antimicrobial activities of some new 1,2,4-triazole derivatives. Molecules 15:2427–2438
Bonde CG, Gaikwad NJ (2004) Synthesis and preliminary evaluation of some pyrazine containing thiazolines and thiazolidinones as antimicrobial agents. Bioorg Med Chem 12:2151–2161
Buckle DR, Rockell CJM, Smith H, Spicer BA (1986) Studies on 1,2,3-triazoles.13. (piperazinylalkoxy)[1]benzopyrano[2,3-d]-1,2,3-triazol-9(1H)-ones with combined H-1 antihistamine and mast-cell stabilizing properties. J Med Chem 29:2262–2267
Chandra JNNS, Sadashiva CT, Kavitha CV, Rangappa KS (2006) Synthesis and in vitro antimicrobial studies of medicinally important novel N-alkyl and N-sulfonyl derivatives of 1-[bis(4-fluorophenyl)-methyl]piperazine. Bioorg Med Chem 14:6621–6627
Demirbas A, Sahin D, Demirbas N, Alpay-Karaoglu S, Bektas H (2010) Synthesis and antimicrobial activities of 2-(5-mercapto)-1,3-oxadiazol-2-ylmethyl-1,2,4-triazol-3-one derivatives. Turk J Chem 34:347–358
Deng XQ, Quan LN, Song MX, Wei CX, Quan ZH (2011) Synthesis and anticonvulsant activity of 7-phenyl-6,7-dihydro-[1,2,4]triazolo [1,5-a]pyrimidin-5(4H)-ones and their derivatives. Eur J Med Chem 46:2955–2963
Dixit PP, Nair PS, Patil VJ, Jain S, Arora SK, Sinha N (2005) Synthesis and antibacterial activity of novel (un)substituted benzotriazolyl oxazolidinone derivatives. Bioorg Med Chem Lett 15:3002–3005
Dixit PP, Patil VJ, Nair PS, Jain S, Sinha N, Arora SK (2006) Synthesis of 1-[3-(4-benzotriazol-1/2-yl-3-fluoro-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-3-substituted-thiourea derivatives as antituberculosis agents. Eur J Med Chem 41:423–428
El-Gaby MSA, El-Hag Ali GAMA, El-Maghraby A, Abd El-Rahman MT, Helal MHM (2009) Synthesis, characterization and in vitro antimicrobial activity of novel 2-thioxo-4-thiazolidinones and 4,4′-bis (2-thioxo-4-thiazolidinone-3-yl)diphenylsulfones. Eur J Med Chem 44:4148–4152
Eswaran S, Adhikari AV, Shetty NS (2009) Synthesis and antimicrobial activities of novel quinoline derivatives carrying 1,2,4-triazole moiety. Eur J Med Chem 44:4637–4647
Faridoon, Hussein WM, Vella P, Islam NU, Ollis DL, Schenk G, McGeary RP (2012) 3-Mercapto-1,2,4-triazoles and N-acylated thiosemicarbazides as metallo-β-lactamase inhibitors. Bioorg Med Chem Lett 22:380–386
Genin MJ, Allwine DA, Anderson DJ, Barbachyn MR, Emmert DE, Garmon SA, Graber DR, Grega KC, Hester JB, Hutchinson DK, Morris J, Reischer RJ, Ford CW, Zurenko GE, Hamel JC, Schaadt RD, Stapert D, Yagi BH (2000) Substituent effects on the antibacterial activity of nitrogen–carbon-linked (azolylphenyl)oxazolidinones with expanded activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis. J Med Chem 43:953–970
Hu C, Solomon VR, Cano P, Lee H (2010) 4-Aminoquinoline derivative that markedly sensitizes tumor cell killing by Akt inhibitors with a minimum cytotoxicity to non-cancer cells. Eur J Med Chem 45:705–709
Hubschwerlen C, Specklin JL, Sigwalt C, Schroeder S, Locher HH (2003) Design, synthesis and biological evaluation of oxazolidinone–quinolone hybrids. Bioorg Med Chem 11:2313–2319
Karthikeyan MS, Prasad DJ, Poojary B, Bhat KS, Holla BS, Kumari NS (2006) Synthesis and biological activity of Schiff and Mannich bases bearing 2,4-dichloro-5-fluorophenyl moiety. Bioorg Med Chem 14:7482–7489
Kategaonkar AH, Shinde PV, Kategaonkar AH, Pasale SK, Shingate BB, Shingare MS (2010) Synthesis and biological evaluation of new 2-chloro-3-((4-phenyl-1H-1,2,3-triazol-1-yl)methyl)quinoline derivatives via click chemistry approach. Eur J Med Chem 45:3142–3146
Kucukguzel SG, Oruc EE, Rollas S, Sahin F, Ozbek A (2002) Synthesis, characterisation and biological activity of novel 4-thiazolidinones, 1,3,4-oxadiazoles and some related compounds. Eur J Med Chem 37:197–206
Kumar GVS, Prasad YR, Mallikarjuna BP, Chandrashekar SM (2010) Syntheses and pharmacological of clubbed isopropylthiazole derived triazolothiadiazoles, triazolothiadiazines and Mannich bases as potential antimicrobial and antitubercular agents. Eur J Med Chem 45:5120–5129
Mallikarjuna BP, Sastry BS, Kumar GVS, Rajendraprasad Y, Chandrashekar SM, Sathisha K (2009) Synthesis of new 4-isopropylthiazole hydrazide analogs and some derived clubbed triazole, oxadiazole ring system—a novel class of potential antibacterial, antifungal and antitubercular agents. Eur J Med Chem 44:4739–4746
Nandhakumar R, Suresh T, Jude ALC, Kannan VR, Mohan PS (2007) Synthesis, antimicrobial activities and cytogenetic studies of newer diazepino quinoline derivatives via Vilsmeier–Haack reaction. Eur J Med Chem 42:1128–1136
Pablos-Mendez A, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F, Chon DL, Weezenbeek CSL, Kim SJ, Chaulet P, Nunn P (1998) Global surveillance for antituberculosis-drug resistance. N Engl J Med 338:1641–1649
Panneerselvam P, Nair RR, Vijayalakshimi G, Subramanian EH, Sridhar SK (2005) Synthesis of Schiff bases of 4-(4-aminophenyl)-morpholine as potential antimicrobial agents. Eur J Med Chem 40:225–229
Patil BS, Krishnamurthy G, Naik HSB, Latthe PR, Ghate M (2010) Synthesis, characterization and antimicrobial studies of 2-(4-methoxy-phenyl)-5-methyl-4-(2-arylsulfanyl-ethyl)-2,4-dihydro-[1,2,4] triazolo-3-ones and their corresponding sulfones. Eur J Med Chem 45:3329–3334
Phillips OA, Udo EE, Ali AAM, Samuel SM (2007) Structure-antibacterial activity of arylcarbonyl- and arylsulfonyl-piperazine 5-triazolylmethyl oxazolidinones. Eur J Med Chem 42:214–225
Ridley JM, Dooley PC, Milnes CT, Witchel HJ, Hancox JC (2004) Lidoflazine is a high affinity blocker of the HERG K+ channel. J Mol Cell Cardiol 36:701–705
Sahin D, Bayrak H, Demirbas A, Demirbas N, Alpay Karaoglu S (2012) Design and synthesis of new 1,2,4-triazole derivatives. Turk J Chem 36:411–426
Silverman RB (2004) The organic chemistry of drug design and drug action, 2nd edn. Elsevier Academic Press, Illinois
Solomon VR, Hua C, Lee H (2010) Design and synthesis of anti-breast cancer agents from 4-piperazinylquinoline: a hybrid pharmacophore approach. Bioorg Med Chem 18:1563–1572
Thomas KD, Adhikari AV, Chowdhury IH, Sumesh E, Pal NK (2011) New quinolin-4-yl-1,2,3-triazoles carrying amides, sulphonamides and amidopiperazines as potential antitubercular agents. Eur J Med Chem 46:2503–2512
Tornoe CW, Sanderson SJ, Mottram JC, Coombs GH, Meldal MJ (2004) Combinatorial library of peptidotriazoles: identification of [1,2,3]-triazole inhibitors against a recombinant Leishmania mexicana cysteine protease. J Comb Chem 6:312–324
Vicini P, Geronikaki A, Incerti M, Zani F, Dearden J, Hewitt M (2008) 2-Heteroarylimino-5-benzylidene-4-thiazolidinones analogues of 2-thiazolylimino-5-benzylidene-4-thiazolidinones with antimicrobial activity: synthesis and structure-activity relationship. Bioorg Med Chem 16:3714–3724
Whiting M, Muldoon J, Lin YC, Silverman SM, Lindstron W, Olson AJ, Kolb HC, Finn MG, Sharpless KB, Elder JH, Fokin VV (2006) Inhibitors of HIV-1 protease by using in situ click chemistry. Angew Chem Int Ed 45:1435–1439
Willanova PA (1993) National Committee for Clinical Laboratory Standard. NCCLS Document M7-A3, vol 13. NCCLS, Villanova
Woods GL, Brown-Elliott BA, Desmond EP, Hall GS, Heifets L, Pfyffer GE, Ridderhof JC, Wallace RJ, Warren NC, Witebsky FG (2003) Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes. Approved Standard NCCLS Document M24-A, pp 18–23
Wyrzykiewicz E, Wendzonka M, Kedzia B (2006) Synthesis and antimicrobial activity of new (E)-4-[piperidino (4′-methylpiperidino-, morpholino-) N-alkoxy]stilbenes. Eur J Med Chem 41:519–525
Xu J, Cao Y, Zhang J, Yu S, Zou Y, Chai X, Wu Q, Zhang D, Jiang Y, Sun Q (2011) Design, synthesis and antifungal activities of novel 1,2,4-triazole derivatives. Eur J Med Chem 46:3142–3148
Yolal M, Basoglu S, Bektas H, Demirci S, Alpay-Karaoglu S, Demirbas A (2012) Synthesis of eperezolid-like molecules and evaluation of their antimicrobial activities. Russ J Bioorg Chem 38:539–549
Yu D, Huiyuan G (2002) Synthesis and antibacterial activity of linezolid analogues. Bioorg Med Chem Lett 12:857–859
Acknowledgments
This Project was supported by Karadeniz Technical University, BAP, Turkey (Ref. No. 8623) and is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Demirci, S., Basoglu, S., Bozdereci, A. et al. Preparation and antimicrobial activity evaluation of some new bi- and triheterocyclic azoles. Med Chem Res 22, 4930–4945 (2013). https://doi.org/10.1007/s00044-013-0498-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-013-0498-3